SCHEMBL477599

SCHEMBL477599

OC(c1ccccc1)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.62
LMNA P02545 1/20 0.62
HPGD P15428 1/20 0.62
ALOX15 P16050 1/20 0.62
TSHR P16473 1/20 0.62
MAPK1 P28482 1/20 0.62
HTT P42858 1/20 0.62
KMT2A Q03164 2/20 0.61
CYP4F2 P78329 1/20 0.57
CYP4A11 Q02928 1/20 0.57
MAOB P27338 5/20 0.56
MEN1 O00255 1/20 0.56
NR4A2 P43354 1/20 0.55
ALOX5 P09917 3/20 0.55
SGMS2 Q8NHU3 1/20 0.55
BCHE P06276 2/20 0.53
MAOA P21397 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31067669 0.91 MAOB (0.71) SMN1; SMN2LMNAHPGDALOX15TSHR
SCHEMBL17064305 0.91 MAOB (0.71) SMN1; SMN2LMNAHPGDALOX15TSHR
SCHEMBL10543846 0.90 MAOB (0.61) SMN1; SMN2LMNAHPGDALOX15TSHR
SCHEMBL7713126 0.90 SMN1; SMN2 (0.56) SMN1; SMN2LMNAHPGDALOX15TSHR
SCHEMBL4707722 0.90 ALOX5 (0.59) SMN1; SMN2LMNAHPGDALOX15TSHR
SCHEMBL4822571 0.88 MAOB (0.68) SMN1; SMN2LMNAHPGDALOX15TSHR
SCHEMBL5772077 0.88 KMT2A (0.62) SMN1; SMN2LMNAHPGDALOX15TSHR
SCHEMBL5911726 0.88 KMT2A (0.62) SMN1; SMN2LMNAHPGDALOX15TSHR
SCHEMBL11603161 0.87 KMT2A (0.63) SMN1; SMN2LMNAHPGDALOX15TSHR
SCHEMBL10956292 0.86 SMN1; SMN2 (0.59) SMN1; SMN2LMNAHPGDALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8563786-B2 Method for producing optically active alcohol MITSUI CHEMICALS, INC. (JP) 2013-10-22 US disclosed
US-20120088938-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2012-04-12 US disclosed
EP-2412694-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL Mitsui Chemicals, Inc. (JP) 2012-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088938-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL ADH1A, ADH1C, FHIT SMN1; SMN2 4362/4885LMNA 1422/4885HPGD 568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.